| 貨號 |
中文名稱 |
英文名詞 |
靶點 |
|
VAPD00154 |
Research Grade Robatumumab ( 羅妥木單抗 ) Biosimilar?
|
|
IGF1R, CD221 |
|
VAPD00153 |
Research Grade burfiralimab Biosimilar?
|
|
VIM, Vimentin |
|
VAPD00152 |
Research Grade sulesomab（硫索單抗） Biosimilar?
|
|
CEACAM6, NCA, CD66c |
|
VAPD00151 |
Research Grade Aselizumab ( 阿塞珠單抗 ) Biosimilar?
|
|
CD62L |
|
VAPD00150 |
Research Grade Pritumumab ( 普林木單抗 ) Biosimilar?
|
|
VIM, Vimentin |
|
VAPD00149 |
Research Grade Bivatuzumab ( 比伐珠單抗 ) Biosimilar?
|
|
CD44 |
|
VAPD00148 |
Research Grade Taplitumomab( 帕他莫單抗 ) Biosimilar?
|
|
CD19 |
|
VAPD00147 |
Research Grade Lemalesomab ( 來馬索單抗 ) Biosimilar?
|
|
CEACAM6, NCA, CD66c |
|
VAPD00146 |
Research Grade Erlizumab ( 厄利珠單抗 ) Biosimilar?
|
|
ITGB2, CD18, MFI7, Integrin beta-2 |
|
VAPD00145 |
Research Grade Vapaliximab ( 伐利昔單抗 ) Biosimilar?
|
|
AOC3, VAP1, SSAO,Vascular adhesion protein 1 |
